Robin Klebig
Impact in
- Rheumatology top 5%
- IgG4-Related and Inflammatory Diseases
-
- Neuroendocrine Tumor Research Advances
Papers in
-
- Lymphoma Diagnosis and Treatment 5
-
- Autoimmune Neurological Disorders and Treatments 1
- Co-authors
- Thomas E. Witzig (7 shared papers)Mark Topazian (1 shared paper)Michael J. Levy (1 shared paper)Suresh T. Chari (1 shared paper)Naoki Takahashi (1 shared paper)Aravind Sugumar (1 shared paper)Phil A. Hart (1 shared paper)Bret T. Petersen (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (2 papers)Leukemia (1 paper)Neurology (1 paper)Gut (1 paper)
- Partner nations
- United States
In The Last Decade
Robin Klebig
7 papers receiving 344 citations
Peers
Comparison fields: 5 of 31
- Rheumatology 249
- Epidemiology 189
- Surgery 213
- Genetics 50
- Pathology and Forensic Medicine 77
Countries citing papers authored by Robin Klebig
This map shows the geographic impact of Robin Klebig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Klebig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Klebig more than expected).
Fields of papers citing papers by Robin Klebig
This network shows the impact of papers produced by Robin Klebig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Klebig. The network helps show where Robin Klebig may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Klebig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 263 | |
| 2 | 2011 | 77 | |
| 3 | 2012 | 6 | |
| 4 | 2023 | 4 | |
| 5 | 2016 | 4 | |
| 6 | 2015 | 2 | |
| 7 | 2016 | 1 | |
| 8 | 2025 | 0 | |
| 9 | 2011 | 0 |
About Robin Klebig
Robin Klebig is a scholar working on Pathology and Forensic Medicine, Neurology, Epidemiology, Surgery and Genetics, having authored 9 papers that have together received 357 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (1 paper), Cancer Genomics and Diagnostics (1 paper), Pancreatitis Pathology and Treatment (1 paper), IgG4-Related and Inflammatory Diseases (1 paper), Lung Cancer Treatments and Mutations (1 paper), Autoimmune Neurological Disorders and Treatments (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Rheumatology (249 citations), Epidemiology (189 citations), Surgery (213 citations), Genetics (50 citations) and Pathology and Forensic Medicine (77 citations). Robin Klebig has collaborated with scholars based in United States. Frequent co-authors include Thomas E. Witzig, Mark Topazian, Michael J. Levy, Suresh T. Chari, Naoki Takahashi, Aravind Sugumar, Phil A. Hart, Bret T. Petersen, Santhi Swaroop Vege and Ferga C. Gleeson. Their work appears in journals such as Journal of Clinical Oncology, Blood, Leukemia, Neurology and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.